Delivery Order SPE2DB20D1100-SPE2DB25FC8M8

Award Date 6/11/25
Potential Completion Date 7/3/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price contract is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of WELIREG 40 MG TABLET 90S. The contract has a firm fixed price of $17,968.39 and a completion date of June 6, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WELIREG 40 MG TABLET 90S. The firm-fixed-price contract has a ceiling value of $17,968.39 and an ultimate completion date of June 18, 2025. The award is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, including the drug WELIREG 40 MG TABLET 90S. The contract has a ceiling value of $17,968.39 and a completion date of February 26, 2025. It is a firm fixed-price contract and is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 contract is for the delivery of WELIREG 40 MG TABLET 90S, with a period of performance through June 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,968.39, is for the delivery of the pharmaceutical product "WELIREG 40 MG TABLET 90S" and is a firm fixed-price contract with a completion date of May 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed price delivery order is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a Delivery Order valued at $17,968.39, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication, with a performance period ending on June 17, 2025. The contract is a Firm Fixed Price arrangement, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $17,368.14 to Amerisourcebergen Drug Corp for the supply of 4564762847 WELIREG 40 MG TABLET 90S. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication WELIREG 40 MG TABLET 90S, with a firm fixed price of $17,968.39 and a completion date of May 22, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC8M8
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WELIREG 40 MG TABLET 90S. The contract has a ceiling value of $17,968.39 and an ultimate completion date of July 3, 2025. It is a firm-fixed-price contract, with no set-aside designation.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order contract is likely part of the company's broader support for federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/10/25, 9:49 AM